Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT2A receptors in Brodmann areas and brain hemispheres

Psychiatry Research

Volumn 111, Issue 2-3, 2002, Pages 105-115

  Rosel, Pilar ^a,b   Arranz, Belén ^b   Urretavizcaya, Mikel ^c   Oros, Miguel ^a   San, Luis ^b   Vallejo, Julio ^c   Navarro, Miguel Angel ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Benito Menni   (Spain)

^c Institut de Reserca Oncologica   (Spain)

Author keywords

5 HT reuptake complex; 5 HT2A receptor; Brodmann areas; Human brain; Laterality; Serotonin

Indexed keywords

IMIPRAMINE; PAROXETINE; POSTSYNAPTIC RECEPTOR; SEROTONIN 2A RECEPTOR; TRITIUM;

ADULT; ARTICLE; BINDING SITE; BRAIN NERVE CELL; BRAIN REGION; BRAIN TISSUE; CINGULATE GYRUS; CONTROLLED STUDY; FRONTAL CORTEX; HEMISPHERE; HEMISPHERIC DOMINANCE; HUMAN; HUMAN TISSUE; MALE; OCCIPITAL CORTEX; PARIETAL LOBE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR BINDING; SEROTONINERGIC SYSTEM; TISSUE DISTRIBUTION;

ADULT; BRAIN MAPPING; CARRIER PROTEINS; CEREBRAL CORTEX; DOMINANCE, CEREBRAL; GYRUS CINGULI; HUMANS; IMIPRAMINE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PAROXETINE; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, PRESYNAPTIC; RECEPTORS, SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0037200639     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(02)00146-4     Document Type: Article

References (35)

1. Arató M., Tekes K., Tothfalusi L., Magyar K., Palkovits M., Demeter E., Falus A. Serotonergic split brain in suicide. Psychiatry Research. 21:1987;355-356.
2. Arora R.C., Meltzer H.Y. Serotonergic measures in the brain of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. American Journal of Psychiatry. 146:1989;730-736.
3. 3H]imipramine binding: studies in the frontal cortex of normal controls and suicide victims. Biological Psychiatry. 29:1991;1016-1022.
4. Andersson A., Eriksson A., Marcusson J. Unaltered number of brain serotonin uptake sites in suicide victims. Journal of Psychopharmacology. 6:1992;509-513.
5. Arranz B., Eriksson A., Mellerup A., Plenge P., Marcusson J. Brain 5-HT1A, 5-HT1D and 5-HT2 receptors in suicide victims. Biological Psychiatry. 35:1994;457-463.
6. 3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study. Journal of Neural Transmission. 97:1994;27-40.
7. Arranz B., Rosel P., San L., Sarró S., Navarro M.A., Marcusson J. Characterization of the 5-HT4 binding site in human brain. Journal of Neural Transmission. 105:1998;575-586.
8. Arranz B., Rosel P., Sarró S., Zaldivar E., Cano R., Navarro M.A., San L. Platelet serotonergic binding sites in alcohol-dependent patients. Alcohol and Alcoholism. 34:1999;726-732.
9. Brodmann K. Description of individual brain maps. Garey L.J., Brodmann's Localisation in the Cerebral Cortex. 1994;107-174 Smith-Gordon, London.
10. Coccaro E.F., Siever L.J. The neuropsychopharmacology of personality disorders. Bloom F.E., Kupfer D.J., Psychopharmacology, the Fourth Generation of Progress. 1995;1567-1580 Raven Press, New York.
11. Cryan J.F., Leonard B.E. 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response. Human Psychopharmacology Clinical and Experimental. 15:2000;113-135.
12. Doménech T., Beleta J., Fernández A.G., Gristwood R.W., Cruz-Sánchez F.F., Tolosa E., Palacios J.M. Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: comparison with other mammalian species. Molecular Brain Research. 21:1994;176-180.
13. 3H]ketanserin binding in the human brain postmortem: effect of suicide. Brain Research. 47:1990;1038-1046.
14. Gross-Isseroff R., Biegon A., Voet H., Weizman A. The suicide brain: a review of postmortem receptor/transporter binding studies. Neuroscience Biobehavior Reviews. 22:1998;653-661.
15. 3H]imipramine localization and relation to serotonin transporter. Journal of Pharmacology and Experimental Therapeutics. 252:1990;410-418.
16. Kingsbury A.E., Foster O.J., Nisbet A.P., Cairns N., Bray L., Eve D.J., Lees A.J., Marsden C.D. Tissue pH as an indicator of mRNA preservation in human postmortem brain. Molecular Brain Research. 21:1995;176-180.
17. 3H]paroxetine, in antidepressant-free depressed suicides. Brain Research. 526:1990;17-22.
18. 3H]ketanserin. European Journal of Pharmacology. 18:1983;125-130.
19. Lowther S., De Parmentier F., Crompton M.R., Katona C.L.E., Horton R.W. Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Research. 642:1994;281-289.
20. Mann J.J., Stanley M., McBride P.A., McEwen B.S. Increased serotonin-2 and β-adrenergic receptor binding in the frontal cortex of suicide victims. Archives of General Psychiatry. 43:1986;954-959.
21. Mann J.J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology. 21:1999;99S-105S.
22. Markwell M.A., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Analytical Biochemistry. 87:1978;203-225.
23. Owen F., Chambers D.R., Cooper S.J., Crow T.J., Johnson J.A., Lofthouse R., Poulter M. Serotonergic mechanism in brains of suicide victims. Brain Research. 362:1986;185-188.
24. 3H]citalopram binding to the 5-HT transporter from brain and platelets. European Journal of Pharmacology. 206:1991;243-250.
25. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cerebral Cortex. 5:1995;307-322.
26. 3H]imipramine binding: influences of protein concentration of varying proportions of cytosol or intact platelets and displacing agents used. Biological Psychiatry. 38:1995;464-470.
27. 3H]imipramine binding in healthy controls: age and gender effects. Biological Psychiatry. 40:1996;981-985.
28. 3H]paroxetine binding sites in suicide brains. Psychiatry Research: Neuroimaging Section. 82:1998;161-170.
29. Rosel P., Arranz B., Oros M., Vallejo J., San L., Marcusson J., Navarro M.A. Different regional distribution of the 5-HT reuptake complex, the 5-HT2A receptors and their second messenger IP3 in human brain. Neuroscience Research Communications. 24:(2):1999;107-115.
30. Roth B.L., Meltzer H.Y. The role of serotonin in schizophrenia. Bloom F.E., Kupfer D.J., Psychopharmacology, the Fourth Generation of Progress. 1995;1215-1228 Raven Press, New York.
31. Stanley M., Virgilio S., Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science. 216:1982;1337-1339.
32. Stanley M., Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. 1:1983;214-216.
33. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. 1988;Thieme Medical Publisher, New York.
34. Wijngaarden I., Tulp M.T., Soudijn W. The concept of selectivity in 5-HT receptor research. European Journal of Pharmacology. 188:1990;301-312.
35. Yates M., Leake A., Candy J.M., Fairbairn A.F., McKeith I.G., Ferrier I.N. 5-HT2 receptor changes in major depression. Biological Psychiatry. 27:1990;489-496.